<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02385981</url>
  </required_header>
  <id_info>
    <org_study_id>ASOKLIF 1301/PA</org_study_id>
    <nct_id>NCT02385981</nct_id>
  </id_info>
  <brief_title>Vagal-stimulation-PAVK-tcpO2-study</brief_title>
  <official_title>Clinical Study to Review the Effects of an Auricular and Percutaneous Electric Stimulation of Nervus Vagus on the Oxygen Supply of Skin of Patients With Severe Claudicatio Intermittens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Payrits, Thomas, M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Payrits, Thomas, M.D.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      H-1: tcpO2U2 &gt; tcpO2U1 H-0: tcpO2U2 â‰¤ tcpO2U1
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">May 2015</completion_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in transcutaneous oxygen partial pressure</measure>
    <time_frame>2015</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>changes in SF 36</measure>
    <time_frame>2015</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>changes in ambulatory ability</measure>
    <time_frame>2015</time_frame>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Improvement of Skin Oxygen Supply</condition>
  <arm_group>
    <arm_group_label>Stivax</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>an intermittent stimulation of afferent vagus nerve at earlap</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stivax</intervention_name>
    <arm_group_label>Stivax</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Each subject must sign an informed consent (ICF) indicating that he or she understands
             the purpose of and procedures required for the study and are willing to participate in
             the study.

          2. PAVK stadium IIb due to Fontaine for at least 6 month

          3. reduced systolic occlusion pressure at ankle (arteria tibialis posterior and
             anterior): ABI &lt;0,9

          4. radiologic significant occlusion at arteria femoralis superficialis and/or at arteria
             poplitea and/or at arteria of lower legs (MRT, CT, CO2-angiography or color-coded
             duplex sonography)

          5. expected availability during study participation over 12 weeks (via health care
             center)

        Exclusion Criteria:

        1) &lt;18 years 2) pregnancy and non-exclusion of pregnancy (women of child-bearing potential)

          -  3)risk of incidence of pregnancy during study participation (female must fulfill one
             of the following criteria: menopause for more than 2 years, postmenopausal
             sterilisation, surgical sterilisation, hormonal contrazeption during study
             participation, spiral or diaphragm/condome+spermicide).

             4) lactation period 5) person of legal incapacity 6) regard, placement or appointment
             of an solicitor 7) military service 8) contraindication for the application of STIVAX
             8a) malignant tumour (existence of a known, histologic verified, malignant tumour) 8b)
             hemophilia 8c) psoriasis vulgaris 8d) recent stroke 8e) superficial and deep infection
             of auricle and external auditory canal 9) (with the exception of STIVAX-application):
             foreseeable relevant stimulation of afferent contents of vagus to the ear within next
             2 weeks.

             10) isolated diabetic microangiopathia 11) implantated cardiac pacemaker or
             defibrillator 12) transcutaneous partial pressure of oxygen (tcpO2) &gt; 50 mmHg 13)
             concomitant disease with potential to limit the significance of the investigation of
             the walk distance (angina pectoris, heart failure, relevant pulmonary disease,
             relevant orthopedic or neurologic disease) 14) concomitant disease with potential to
             improve or to worsen the walking or the perfusion of the extremities in a relevant
             way.

             15) foreseeable change of PAVK-relevant medication or of concomitant medication with
             the potential to improve or to worsen the walking or the perfusion of the extremities
             in a relevant way within next 2 weeks.

             16) foreseeable start of a structured walking training within the next 2 weeks. 17)
             change in PAVK relevant medication or concomitant medication with potential to improve
             or worsen the walking or the perfusion of the extremities in a relevant way within the
             last 3 months.

             18) start with structured walking training within the last 3 months. 19) change in
             smoking habits within the last 3 months. 20) simultaneous participation in another
             clinical trial with insurance-protection.

             21) use of a therapy with stimulation of the afferent parts of vagus on the ear in the
             past.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Thomas Payrits, OA Dr.</last_name>
    <phone>+43/676833212627</phone>
    <email>thomas.payrits@wienerneustadt.lknoe.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Landesklinikum Wiener Neustadt</name>
      <address>
        <city>Wiener Neustadt</city>
        <state>Lower Austria</state>
        <zip>2700</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Payrits, OA Dr.</last_name>
      <phone>+43/676 83321 2627</phone>
      <email>thomas.payrits@wienerneustadt.lknoe.at</email>
    </contact>
    <investigator>
      <last_name>Thomas Payrits, OA Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 23, 2014</study_first_submitted>
  <study_first_submitted_qc>March 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 11, 2015</study_first_posted>
  <last_update_submitted>March 10, 2015</last_update_submitted>
  <last_update_submitted_qc>March 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

